Research & Literature

Non-Bacterial Thrombotic Endocarditis in a Patient with Rheumatoid Arthritis.

Choi JH, Park JE, Kim JY, Kang T

Korean circulation journal 2016; (46(3)):425-8 doi:10.4070/kcj.2016.46.3.425.

Libman-Sacks Endocarditis in a Patient With Antiphospholipid Syndrome.

Kotkar KD, Said SM

The Annals of thoracic surgery 2016; (102(1)):e31-2.

Nonbacterial Thrombotic Endocarditis: Pathogenesis, Diagnosis, and Management.

Liu J, Frishman WH

Cardiology in review 2016; (24(5)):244-7 doi:10.1097/CRD.0000000000000106.

An update on intraoperative three-dimensional transesophageal echocardiography.

Rong LQ

Journal of thoracic disease 2017; (9(Suppl 4)):S271-S282 doi:10.21037/jtd.2017.03.123.

Autoimmune Disease with Cardiac Valves Involvement: Libman-Sacks Endocarditis.

Ginanjar E, Yulianto Y

Acta medica Indonesiana 2017; (49(2)):148-150.

Role of 3D Echocardiography in Cardiac Surgery: Strengths and Limitations.

Turton EW, Ender J

Current anesthesiology reports 2017; (7(3)):291-298 doi:10.1007/s40140-017-0226-5.

Drug-Induced by Systemic Lupus Erythematosus Presenting as Recurrent Pericardial Effusion After Mitral Valve Repair.

Haydari A, Sabzi F, Dabiri S, Poormotaabed A

Acta medica Iranica 2017; (55(9)):597-601.

Improvement of Libman-Sacks Endocarditis With Combined Hydroxychloroquine-Vitamin K Antagonist Therapy in a Primary Antiphospholipid Syndrome Patient.

Omarjee L, Jaquinandi V, Camarzana A, et al.

Circulation journal : official journal of the Japanese Circulation Society 2018; (82(9)):2380-2382 doi:10.1253/circj.CJ-17-1131.

Mitral valve replacement for Libman-Sacks endocarditis in a patient with antiphospholipid syndrome secondary to systemic lupus erythematosus.

Nakasu A, Ishimine T, Yasumoto H, et al.

Journal of surgical case reports 2018; (2018(4)):rjy069 doi:10.1093/jscr/rjy069.

Active NET formation in Libman-Sacks endocarditis without antiphospholipid antibodies: A dramatic onset of systemic lupus erythematosus.

Appelgren D, Dahle C, Knopf J, et al.

Autoimmunity 2018; (51(6)):310-318 doi:10.1080/08916934.2018.1514496.

Libman-Sacks Endocarditis Involving a Bioprosthesis in the Aortic Valve Position in Systemic Lupus Erythematosus.

Roberts WC, Lee AY, Lander SR, et al.

The American journal of cardiology 2019; (124(2)):316-318 doi:10.1016/j.amjcard.2019.04.031.

Immunosuppressive therapy to reduce mitral regurgitation in Libman-Sacks endocarditis: a case report.

Ishizu K, Isotani A, Yamaji K, Ando K

European heart journal. Case reports 2019; (3(3)) doi:10.1093/ehjcr/ytz133.

Libman-Sacks endocarditis in patients with systemic lupus erythematosus with secondary antiphospholipid syndrome.

Mohammadi Kebar Y, Avesta L, Habibzadeh A, Hemmati M

Caspian journal of internal medicine 2019; (10(3)):339-342 doi:10.22088/cjim.10.3.339.

Cardio-Rheumatology: Cardiovascular Complications in Systemic Autoimmune Rheumatic Diseases / Is Inflammation the Common Link and Target?

Manolis AS, Tzioufas AG

Current vascular pharmacology 2020; (18(5)):425-430 doi:10.2174/1570161118666200514222236.

Clinical characteristics and long-term outcomes of Libman-Sacks endocarditis in patients with systemic lupus erythematosus.

Yoo BW, Lee SW, Song JJ, et al.

Lupus 2020; (29(9)):1115-1120 doi:10.1177/0961203320930097.

Cardio-Rheumatology: Two Collaborating Disciplines to Deal with the Enhanced Cardiovascular Risk in Autoimmune Rheumatic Diseases.

Manolis AS, Tzioufas AG

Current vascular pharmacology 2020; (18(6)):533-537 doi:10.2174/1570161118666200721145718.

Non-Bacterial Thrombotic Endocarditis: A Case of Metastatic Pancreatic Cancer Masquerading as Infective Endocarditis.

Randhawa G, Aslam A, Suarez MJ, et al.

Cureus 2020; (12(7)):e9103 doi:10.7759/cureus.9103.

A Contemporary 20-Year Cleveland Clinic Experience of Nonbacterial Thrombotic Endocarditis: Etiology, Echocardiographic Imaging, Management, and Outcomes.

Zmaili MA, Alzubi JM, Kocyigit D, et al.

The American journal of medicine 2021; (134(3)):361-369 doi:10.1016/j.amjmed.2020.06.047.

Catastrophic antiphospholipid syndrome associated with systemic lupus erythematosus: a case-based review.

Garcia-Diaz J, Escudero-Salamanca M, Alvarez-Santana R, Espinola-Zavaleta N

Future cardiology 2021; (17(6)):985-990 doi:10.2217/fca-2020-0145.

[Libman-Sacks endocarditis under apixaban in a patient with a high-risk profile venous antiphospholipid syndrome].

Allain JS, Paven E, Henriot B, et al.

La Revue de medecine interne 2021; (42(3)):218-222 doi:10.1016/j.revmed.2020.08.009.

Severe mitral valve regurgitation secondary to Libman-Sacks endocarditis.

Mizrahi M, Jimenez-Becerra S, Rivera-Navarrete E, Gomez-Sanchez M

American journal of cardiovascular disease 2020; (10(4)):382-385.

Mitral valve 'kissing lesion' in Libman-Sacks endocarditis.

Sadeghpour A, Pourafkari L, Nader ND

QJM : monthly journal of the Association of Physicians 2021; (114(5)):338 doi:10.1093/qjmed/hcaa342.

Mitral Valve Repair for Isolated Libman-Sacks Endocarditis in a Patient with Primary Antiphospholipid Syndrome.

Ye T, Wang J, Liao S

International heart journal 2021; (62(1)):181-185 doi:10.1536/ihj.20-260.

Libman-Sacks endocarditis and associated cerebrovascular disease: The role of medical therapy.

Roldan CA, Sibbitt WL, Greene ER, et al.

PloS one 2021; (16(2)):e0247052 doi:10.1371/journal.pone.0247052.

Neurologic complications of nonbacterial thrombotic endocarditis.

Dafer RM

Handbook of clinical neurology 2021; (177()):135-141 doi:10.1016/B978-0-12-819814-8.00013-5.

Non-Bacterial Thrombotic Endocarditis as a Cause of Cryptogenic Stroke in Malignancy.

Ilyas S, Lang W, Belani N, Stockwell P

Rhode Island medical journal (2013) 2021; (104(2)):63-66.

Aortic valve surgery for aortic regurgitation caused by Libman-Sacks endocarditis in a patient with primary antiphospholipid syndrome: a case report.

Le Ho Y, Ahmad Zaidi NA, Salleh A, Abdul Kareem BA

Journal of cardiothoracic surgery 2021; (16(1)):92 doi:10.1186/s13019-021-01458-2.

Cardiogenic Shock and Mitral Valve Chord Rupture: A Rare Presentation of Libman-Sacks Endocarditis.

Lampert J, Halista M, Pujadas E, et al.

JACC. Case reports 2020; (2(12)):1988-1991 doi:10.1016/j.jaccas.2020.06.044.

A Case of Systemic Lupus Erythematosus in a Patient Presenting with Libman-Sacks Endocarditis.

Al-Jehani M, Al-Husayni F, Almaqati A, et al.

Case reports in cardiology 2021; (2021()):5573141 doi:10.1155/2021/5573141.

Cardiovascular Complications in Systemic Lupus Erythematosus.

Alghareeb R, Hussain A, Maheshwari MV, et al.

Cureus 2022; (14(7)):e26671 doi:10.7759/cureus.26671.

A New Insight Into Nonbacterial Thrombotic Endocarditis: A Systematic Review of Cases.

Venepally NR, Arsanjani R, Agasthi P, et al.

Anatolian journal of cardiology 2022; (26(10)):743-749 doi:10.5152/AnatolJCardiol.2022.1282.

Antiphospholipid syndrome: advances in diagnosis, pathogenesis, and management.

Knight JS, Branch DW, Ortel TL

BMJ (Clinical research ed.) 2023; (380()):e069717 doi:10.1136/bmj-2021-069717.

Multivalvular involvement associated with Libman-Sacks endocarditis detected by multimodality imaging: A case report.

Bui STT, Nguyen PH, Nguyen TN, et al.

Frontiers in cardiovascular medicine 2023; (10()):1117711 doi:10.3389/fcvm.2023.1117711.

Libman-Sacks Endocarditis Presenting as Acute Coronary Syndrome, Acute Heart Failure and Multiple Embolic Strokes.

Banerjee S, Ahmed M, Osei-Sarpong J, et al.

Cureus 2023; (15(5)):e38849 doi:10.7759/cureus.38849.

Case report of culture-negative endocarditis in lupus nephritis.

Khandait H, Ong CK, Javaid A, Sandhu R

European heart journal. Case reports 2023; (7(7)):ytad290 doi:10.1093/ehjcr/ytad290.

Acute cardiovascular complications of immune-mediated systemic inflammatory diseases.

Weber BN, Garshick M, Abbate A, et al.

European heart journal. Acute cardiovascular care 2023; (12(11)):792-801 doi:10.1093/ehjacc/zuad096.

Novel 3D versus traditional transesophageal echocardiography techniques: Defining differences in the diagnosis of infective endocarditis.

Tomoaia R, Beyer RȘ, Dădârlat-Pop A, et al.

European journal of clinical investigation 2024; (54(2)):e14103 doi:10.1111/eci.14103.

Post-cardiac Injury Syndrome in a Systemic Lupus Erythematosus Patient After an Open-Heart Operation: A Case Report.

Abuhammad A, Nassar O, Atawnah SI

Cureus 2023; (15(9)):e46077 doi:10.7759/cureus.46077.

Embolic Phenomena of Libman-Sacks Endocarditis and Antiphospholipid Syndrome.

Gorantla A, Schaible M, Sivakumar SS, et al.

Cureus 2023; (15(10)):e46957 doi:10.7759/cureus.46957.

An Incidental Finding of Libman-Sacks Endocarditis ‎in a Young Female With Systemic Lupus Erythematosus Who Presented With Pleuritic Chest Pain.

Alhashem AT, Hassan WM

Cureus 2023; (15(11)):e49672 doi:10.7759/cureus.49672.

The impact of Libman-sacks endocarditis on inpatient outcomes with systemic lupus erythematosus: A retrospective study.

Alfatlawi H, Alharbi A, Shah M, et al.

Lupus 2024; (33(7)):693-699 doi:10.1177/09612033241243179.

Vintage Victory: Warfarin Versus Apixaban in the Antiphospholipid Arena.

Sabina M, Barakat Z, Costa Guerra B, et al.

Cureus 2024; (16(3)):e57040 doi:10.7759/cureus.57040.

The Emerging Specialty of Cardio-Rheumatology.

Nayfeh M, DiGregorio H, Saad JM, et al.

Current atherosclerosis reports 2024; (26(9)):499-509 doi:10.1007/s11883-024-01221-7.

Impact of antiphospholipid antibodies on cardiac valve lesions in systemic lupus erythematosus: a systematic review and meta-analysis.

Chen S, Zhou Y, Wang C, et al.

Clinical and experimental medicine 2024; (24(1)):147 doi:10.1007/s10238-024-01406-z.

Pathological Findings of Embolus Retrieved by Mechanical Thrombectomy in Cerebral Embolism with Libman-Sacks Endocarditis.

Kodera H, Sakamoto Y, Aoki J, et al.

Internal medicine (Tokyo, Japan) 2025; (64(4)):603-607 doi:10.2169/internalmedicine.3212-23.

Cardio-Rheumatology Insights Into Hypertension: Intersection of Inflammation, Arteries, and Heart.

Akhtari S, Harvey PJ, Eder L

American journal of hypertension 2024; (37(12)):933-942 doi:10.1093/ajh/hpae098.

[Stroke and vegetations on cardiac valves - Case report].

Jonsdottir S, Jonsdottir T, Sveinsson OA

Laeknabladid 2025; (111(3)):119-121 doi:10.17992/lbl.2025.03.831.

Impact of antiphospholipid antibodies on heart valve involvements in systemic lupus erythematosus: based on CSTAR cohort.

Chen S, Huang C, Jiang H, et al.

Lupus science & medicine 2025; (12(1)) doi:10.1136/lupus-2025-001674.

Evaluating the Efficacy and Safety of Direct Oral Anticoagulants Compared to Vitamin K Antagonists in Patients with Antiphospholipid Syndrome: Updated Systematic Review and Meta-Analysis.

Alfehaid L, Alsuhebany N, Albahlal H, et al.

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2025; (31()):10760296251364269 doi:10.1177/10760296251364269.

Left Ventricle Libman-Sacks Endocarditis Secondary to Systemic Lupus Erythematosus and Antiphospholipid Syndrome: A Case Report.

Yang ZH, Gong WQ, Liu Y, Zheng MJ

The American journal of case reports 2025; (26()):e949826 doi:10.12659/AJCR.949826.

Systemic Lupus Erythematosus With Catastrophic APS and Libman-Sacks Endocarditis in a Patient With Autoimmune Hemolytic Anemia: A Case Report.

Ehsan S, Afshar S, Bakhtiari S, et al.

Clinical case reports 2025; (13(12)):e71552 doi:10.1002/ccr3.71552.

Cardiac Involvement in Systemic Lupus Erythematosus.

Vyas V, Vyas V, Sharma A, Kumar PA

Reviews in cardiovascular medicine 2025; (26(11)):42760 doi:10.31083/RCM42760.

Papillary Fibroelastoma of the Aortic Root Causing Intermittent Coronary Ostial Obstruction: The Diagnostic Power of 3D Transesophageal Echocardiography.

Bečić T, Perković-Avelini R, Fabijanić D

Diagnostics (Basel, Switzerland) 2026; (16(1)) doi:10.3390/diagnostics16010168.

Pulmonary Embolism in Antiphospholipid Syndrome (APS)-Where Are We and Where Are We Going?

Lucki M, Grygiel-Górniak B, Lucka E, et al.

International journal of molecular sciences 2026; (27(2)) doi:10.3390/ijms27020895.

Clinical Features and Outcome of Neuropsychiatric Manifestations in Juvenile Onset Systemic Lupus Erythematosus.

Prabhudesai A, Chatterjee R, Lawrence A, et al.

Indian journal of pediatrics 2026; (93(6)):592-598 doi:10.1007/s12098-026-06167-z.

A rare presentation of nonbacterial thrombotic endocarditis.

Jose C, Andre P, Langsfeld J, et al.

Journal of vascular surgery cases and innovative techniques 2026; (12(5)):102337 doi:10.1016/j.jvscit.2026.102337.

Cardiovascular risk goal attainment in the United States rheumatologic population.

Granstaff K, Jiang S, Nallagatla S, Grodzinsky A

American journal of preventive cardiology 2026; (28()):101611 doi:10.1016/j.ajpc.2026.101611.